Related Experiment Video
Updated: Oct 23, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
IntraIndividual Variability in Serum Alpha-1 Antitrypsin Levels.
Annie Haillot1, Andrée-Anne Pelland1, Yohan Bossé1
1Centre de Pneumologie, Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada.
Test-retest reproducibility of alpha-1 antitrypsin (AAT) serum levels is weak, potentially leading to misclassification of alpha-1 antitrypsin deficiency (AATD) and missed diagnoses. Fibrinogen levels correlated with AAT measurements.
Area of Science:
- Pulmonary Medicine
- Clinical Chemistry
- Diagnostic Accuracy
Background:
- Alpha-1 antitrypsin (AAT) serum level measurement is a primary diagnostic step for alpha-1 antitrypsin deficiency (AATD).
- Variability in AAT serum levels between measurements and its association with inflammation markers are not well-understood.
Purpose of the Study:
- To assess the test-retest reproducibility of serum AAT levels.
- To investigate if variability in AAT measurements correlates with acute phase markers of inflammation.
Main Methods:
- Retrospective analysis of 255 patients with COPD undergoing two AAT serum level measurements.
- Measurement of white blood cell count and fibrinogen as inflammation markers during the second blood draw.
- Statistical analysis including ICC, Pearson correlation, Bland-Altman, and regression analyses.
Main Results:
- Weak between-measurement agreement for AAT serum levels (ICC=0.38, Pearson=0.34).
- Discrepancies in AAT levels led to reconsidering further investigation in 22% of patients.
- A significant correlation was found between fibrinogen levels and the second AAT measurement (r=0.21, p=0.004).
Conclusions:
- Serum AAT levels exhibit poor intra-individual reproducibility.
- This variability poses a risk for misclassifying AATD status and potentially missing diagnoses.
- Inflammation markers like fibrinogen may influence AAT serum levels.
More Related Videos
Related Concept Videos
Dosage Regimen: Individualization
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Serum Studies: Renal Function Tests
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...

